【24h】

Thyrotoxicosis – investigation and management

机译:甲状腺毒症–调查和管理

获取原文
           

摘要

Graves disease (GD) and toxic nodular (TN) goitre account for most cases of thyrotoxicosis associated with hyperthyroidism. Hyperthyroidism is confirmed with measurement of a suppressed serum thyrotropin concentration (TSH) and elevated free thyroid hormones. The three therapeutic options are antithyroid drugs, radioactive iodine and surgery. Thionamides achieve long-term remission in 35% of cases. Many centres administer fixed doses of iodine-131; larger doses result in improved rates of cure at the cost of hypothyroidism. Surgery is usually considered for patients who have a large goitre, compressive symptoms or significant ophthalmopathy.
机译:格雷夫斯病(GD)和毒性结节性(TN)甲状腺肿占甲状腺功能亢进症伴甲状腺毒症的大多数病例。甲状腺功能亢进症可通过测量血清促甲状腺激素浓度(TSH)和游离甲状腺激素升高来确认。三种治疗选择是抗甲状腺药,放射性碘和手术。亚硫酰胺可在35%的情况下实现长期缓解。许多中心使用固定剂量的碘131。较大剂量可提高治愈率,但以甲状腺功能减退为代价。通常针对患有大甲状腺肿,压迫症状或严重眼病的患者考虑手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号